November 27th 2024
While name brands like Adderall and Vyvanse may have been recently removed from the FDA Drug Shortage Database, it's unclear if it'll last; meanwhile, many generic forms of attention-deficit/hyperactivity disorder (ADHD) medication are still in short supply.
First 100 Days: Top Healthcare Changes Under the Trump Administration
April 29th 2017Saturday marks the 100th day of Donald Trump’s presidency, and closes out the time period during which a president’s power and influence are supposed to be greatest. As a result, the first 100 days are used to measure the successes and accomplishments of a new president.
Read More
Infographic: A Look Back at Healthcare Steps in Trump's First 100 Days
April 29th 2017In the first 100 days of his administration, President Donald J. Trump has taken a number of actions that could impact healthcare, including filling a Supreme Court seat and taking steps to repeal the Affordable Care Act. Here's a look back at some of the most notable healthcare-related happenings in Trump's first 100 days in office.
Read More
5 Ways the ACO Coalition Prepares Attendees for the Future of Healthcare
April 28th 2017When the ACO & Emerging Healthcare Delivery Coalition® meets May 4-5 in Scottsdale, Arizona, attendees will learn the latest on healthcare reform, best practices for cybersecurity, population health strategies, and more.
Read More
This Week in Managed Care: April 21, 2017
April 21st 2017This week, the top managed care stories included a new rule from CMS to end abuse on the Affordable Care Act insurance exchanges; a study that indicates type 2 diabetes may possibly be reversed; and CareMore unveils a new care model that takes place in the dentist's chair.
Watch
Australian Study Details Diagnosis Delays for Children With Rare Diseases
April 20th 2017Despite the wide variety of rare diseases out there, children and families living with rare disease have one thing in common: they experience diagnostic delays. A new study in Orphanet Journal of Rare Diseases described experiences of seeking and receiving a diagnosis of a rare disease and access to healthcare.
Read More
How to Create Successful Alternative Payment Models in Oncology
April 17th 2017By identifying ways to improve cancer care and then designing alternative payment models (APMs) to overcome current payment barriers, APMs can enable oncology practices to deliver better care to patients and save money for payers in a way that is financially sustainable for the practices.
Read More
Public Support for ACA Continues to Trend Upwards, Particularly Among Young Americans
April 5th 2017Several polls released this week show that Americans’ opinions of the Affordable Care Act (ACA) are steadily becoming more positive, as approval of the law has topped 50% for the first time amidst unsuccessful efforts to repeal and replace it.
Read More
The Latest in the Move to Value-Based Reimbursement and Remaining Challenges
April 4th 2017Panelists, during a session on value and value-based reimbursement at the Academy of Managed Care Pharmacy Annual Meeting, held March 27-30 in Denver, Colorado, discussed the benefits and challenges of value-based contracting and the current and evolving use of value frameworks.
Read More
Analyzing the Near-Term Pipeline for Specialty Drugs
March 28th 2017The Academy of Managed Care Pharmacy Annual Meeting kicked off on March 28, 2017, in Denver, Colorado, with a look at the specialty pharmaceutical pipeline with Aimee Tharaldson, PharmD, senior clinical consultant for emerging therapeutics at Express Scripts.
Read More
This supplement showcases the winning papers and case studies from the PAN Challenge, which aimed to stimulate a dialogue on ways to reduce or eliminate the barriers and disparities that Medicare and ACA enrollees face in obtaining medications to treat life-threatening, chronic, and rare diseases.
Read More
Four Issues for Trump, Now That the ACA Remains the "Law of the Land"
March 27th 2017Questions about cost-sharing subsidies, risk corridors, and what to do about red state Medicaid expansion will confront the Trump administration no matter how much the president wants to move on to other issues.
Read More